Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.

about

Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.

Item

http://www.wikidata.org/entity/Q39375298

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Matrix metalloproteases-respon ...... eting diagnosis and treatment.

@en

Matrix metalloproteases-respon ...... eting diagnosis and treatment.

@nl

type

Item

label

Matrix metalloproteases-respon ...... eting diagnosis and treatment.

@en

Matrix metalloproteases-respon ...... eting diagnosis and treatment.

@nl

prefLabel

Matrix metalloproteases-respon ...... eting diagnosis and treatment.

@en

Matrix metalloproteases-respon ...... eting diagnosis and treatment.

@nl

P1476

Matrix metalloproteases-respon ...... geting diagnosis and treatment

@en

P2093

Huile Gao

http://www.w3.org/2001/XMLSchema#string

Jingyuan Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

Progress and perspectives on targeting nanoparticles for brain drug delivery.

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

Matrix metalloproteinases: regulators of the tumor microenvironment

Extracellularly activatable nanocarriers for drug delivery to tumors.

Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.

Determination of protease cleavage site motifs using mixture-based oriented peptide libraries.

Smart hybrid materials by conjugation of responsive polymers to biomacromolecules.

Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.

Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer pa

Development of selective inhibitors and substrate of matrix metalloproteinase-12.

P304

440-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02652048.2017.1343873

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Huile Gao

Jingyuan Xiong

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28617063

http://www.w3.org/2001/XMLSchema#string

P921

nanomaterial